The kallikrein system in retinal damage/protection

Tomomi Masuda1, Masamitsu Shimazawa1, Hideaki Hara1

  • 1Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.

Summary

Tissue kallikrein, unlike plasma kallikrein, protects against eye diseases by normalizing retinal permeability and inhibiting neovascularization. Its mechanism involves cleaving vascular endothelial growth factor (VEGF).